Study guide
12.2 Interdisciplinary Collaboration, SBAR Communication, and Care Coordination
AAHFN Certified Heart Failure Nurse CHFN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Patient History, Risk Factors, and Etiologies
1.1 Heart Failure Etiologies, Risk Factors, and Comorbid Conditions 1.2 Clinical History Taking, Social Determinants of Health, and Device History 1.3 Recognizing Signs and Symptoms of Heart Failure Decompensation
2 Chapter 2: Physical Examination and Hemodynamic Evaluation
2.1 Physical Assessment of Volume and Congestion Status 2.2 Physical Assessment of Perfusion and Low-Output States 2.3 Hemodynamic Profiling and Invasive Hemodynamics
3 Chapter 3: Laboratory Biomarkers and Diagnostic Testing
3.1 Natriuretic Peptides: BNP and NT-proBNP in Clinical Practice 3.2 Essential Laboratory Panels: Renal, Electrolyte, Hepatic, and Iron Evaluation 3.3 Diagnostic Imaging, ECG, and Device Interrogation
4 Chapter 4: Classification, Staging, and Functional Assessment
4.1 ACC/AHA Stages and LVEF Phenotypes 4.2 NYHA Functional Classification, 6-Minute Walk, and Quality-of-Life Measures 4.3 Frailty, Orthostatic Hypotension, and Age-Friendly Care Frameworks
5 Chapter 5: Individualized Care Planning and Shared Decision-Making
5.1 Care Setting Determination and Acuity Stratification 5.2 Formulating Etiology-Directed and Comorbidity-Integrated Goals 5.3 Shared Decision-Making, Patient Preferences, and Social Determinants
6 Chapter 6: GDMT Pharmacotherapy for HFrEF
6.1 The Four Pillars of GDMT: ARNI/ACEi/ARB, Beta-Blockers, MRA, and SGLT2i 6.2 Second-Line and Specialized Pharmacotherapy: Ivabradine, Vericiguat, Digoxin, and Hydralazine-Nitrates 6.3 Medications to Avoid and Drug Safety in Heart Failure
7 Chapter 7: Diuretics, HFpEF, Comorbidity Pharmacotherapy, and Medication Safety
7.1 Diuretic Strategies: Loop Diuretics, Conversions, and Sequential Nephron Blockade 7.2 Management of Heart Failure with Preserved (HFpEF), Mildly Reduced (HFmrEF), and Improved Ejection Fraction (HFimpEF) 7.3 Comorbidity-Directed Pharmacotherapy: Iron Repletion, Anticoagulation, and Immunizations 7.4 Medication Reconciliation, Adjunct Agents, and Drug-Level Monitoring
8 Chapter 8: Device Therapy, Rhythm Management, and Advanced Interventions
8.1 Implantable Devices: ICD and CRT Indications, Titration, and Screening 8.2 Advanced Heart Failure Therapies: Inotropes, Mechanical Circulatory Support (LVAD), and Heart Transplantation 8.3 Ambulatory Hemodynamic Monitoring and Ultrafiltration
9 Chapter 9: Patient Education, Self-Care, Screening, and Referrals
9.1 Self-Care Education and Daily Weight Monitoring 9.2 Dietary Sodium, Fluid Management, and Lifestyle Modifications 9.3 Exercise Prescription, Cardiac Rehabilitation, and Health Literacy 9.4 Individualized Teaching Plans and Learning Methods 9.5 Comorbidity Screening, Stress Management, and Referral Pathways
10 Chapter 10: Therapy Effectiveness, Monitoring, and Care Transitions
10.1 Monitoring and Titration Evaluation: GDMT Tolerance, Lab Trends, and Hemodynamics 10.2 Outpatient and Remote Monitoring Systems 10.3 Post-Acute Care Transitions and Preventing 30-Day Readmissions
11 Chapter 11: Patient Comprehension, Self-Care Adherence, and Palliative Transitions
11.1 Evaluating Patient and Caregiver Education Comprehension 11.2 Identifying and Addressing Adherence Barriers 11.3 Palliative Care, Goals of Care, and End-of-Life Device Management
12 Chapter 12: Professional Standards, Ethics, Quality, and Certification
12.1 Legal Parameters, Ethical Principles, and Patient Advocacy 12.2 Interdisciplinary Collaboration, SBAR Communication, and Care Coordination 12.3 Evidence-Based Guidelines, Quality Improvement, and Addressing Disparities 12.4 Certification, Continuing Education, and Professional Development
12.2 Interdisciplinary Collaboration, SBAR Communication, and Care Coordination
Key Takeaways Explain This Topic AI
Multidisciplinary heart failure disease management programs carry a Class 1 recommendation in the 2022 AHA/ACC/HFSA guideline to reduce hospitalization risk and improve outcomes through coordinated care.
The SBAR (Situation, Background, Assessment, Recommendation) framework structures clinical communication, preventing ambiguous handoffs and accelerating provider interventions during acute clinical deterioration.
Motivational Interviewing (MI) deploying the OARS framework (Open-ended questions, Affirmations, Reflective listening, Summarizing) elicits patient 'change talk' and resolves ambivalence regarding sodium reduction and medication adherence.
Protocol-driven nurse-led heart failure titration clinics achieve target guideline doses of neurohormonal therapies faster and with equal or superior safety compared to routine physician-only visits.
Effective interdisciplinary collaboration integrates clinical pharmacists for complex medication reconciliation, medical social workers for social determinant barriers, and palliative care specialists for concurrent symptom management.
Last updated: September 2026
Quick Overview: Managing the complexities of heart failure demands seamless interdisciplinary collaboration across inpatient, outpatient, and community care environments. No single discipline possesses the bandwidth or specialized expertise to address the physiological, pharmacological, nutritional, and psychosocial challenges confronting heart failure patients. The Certified Heart Failure Nurse (CHFN) acts as the collaborative centerpiece—orchestrating communication via structured tools like SBAR, resolving patient ambivalence through motivational interviewing, and leading specialized titration clinics that drastically improve guideline-directed medical therapy (GDMT) adherence and patient survival.
The Interdisciplinary Team Model in Heart Failure
Decades of clinical trial data confirm that specialized heart failure disease management programs led by multidisciplinary teams achieve superior clinical outcomes compared to fragmented, uncoordinated care. The 2022 AHA/ACC/HFSA guidelines award a Class 1 recommendation to multidisciplinary heart failure disease management programs for patients with heart failure to reduce hospitalizations and mortality. ┌──────────────────────────────┐
- │ Heart Failure Cardiologist │
- │ & Advanced Practice Clinician│
- └──────────────┬───────────────┘
- │
- ▼
- ┌─────────────────────────────┐ ┌───────────────────┐ ┌─────────────────────────────┐
- │ Clinical Pharmacist │◀─▶│ CHFN / Nurse │◀─▶│ Registered Dietitian │
- │ • GDMT optimization │ │ Coordinator │ │ • 2,000 mg Na limit │
- │ • Drug-drug interactions │ │ • Care navigation │ │ • Fluid restriction balance │
- │ • Financial assistance nav │ │ • Titration lead │ │ • Cardiac cachexia rescue │
- └─────────────────────────────┘ └─────────┬─────────┘ └─────────────────────────────┘
- │
- ┌─────────────────────────────────┼─────────────────────────────────┐
- ▼ ▼ ▼
- ┌───────────────────┐ ┌───────────────────┐ ┌───────────────────┐
- │Medical Social │ │Cardiac Rehab & │ │Palliative Care │
- │Worker (MSW) │ │PT/OT Specialists │ │Specialist │
- │• SDOH mitigation │ │• Supervised ex │ │• Symptom relief │
- │• Transportation │ │• Functional status│ │• Goal alignment │
- │• Home health care │ │• Energy conserve │ │• Concurrent care │
- └───────────────────┘ └───────────────────┘ └───────────────────┘
- Core Multidisciplinary Team Members and Roles
Discipline Primary Clinical Focus Key Heart Failure Interventions Clinical & Outcome Impact
Heart Failure Cardiologist / APC Medical oversight, diagnostic workup, invasive hemodynamics Advanced diagnostic phenotyping, endomyocardial biopsy, surgical/device referral Directs complex medical and surgical therapy; optimizes hemodynamics
Certified Heart Failure Nurse (CHFN) Care coordination, disease education, outpatient triage Protocolized GDMT titration, remote monitoring surveillance, teach-back education Supports fewer readmissions and ED visits through coordinated follow-up
Clinical Pharmacist Pharmacotherapy optimization, safety, polypharmacy Medication reconciliation, renal dosing adjustments, drug interaction intercepts, copay assistance navigation Drastically decreases adverse drug events; accelerates target GDMT dosing
Registered Dietitian (RDN) Nutritional assessment, dietary sodium/fluid coaching Tailoring sodium intake (<2,000-2,300 mg/day), fluid restriction (1.5-2 L/day), managing cardiorenal-diabetic diets Prevents fluid congestion; treats cardiac cachexia and protein malnutrition
Medical Social Worker (MSW) Social determinants of health (SDOH), resource linkage Navigating insurance coverage, Medicaid enrollment, pharmaceutical assistance programs, home health care, transportation Eliminates socioeconomic barriers; mitigates financial toxicity
Cardiac Rehabilitation Specialist Exercise prescription, functional conditioning Monitored aerobic and resistance training, 6-minute walk distance (6MWD) tracking Improves peak VO₂, functional independence, and mood
Physical & Occupational Therapists Functional mobility, ADLs, energy conservation Fall risk mitigation, assistive device training, pacing activities of daily living Prevents falls in hypotensive/frail patients; preserves self-care capacity
Palliative Care Specialist Symptom burden mitigation, goal-of-care clarification Managing refractory dyspnea, nausea, and chronic pain; advance care planning; family goal alignment Improves quality of life (KCCQ scores); ensures dignified end-of-life transitions
Structured Clinical Communication: The SBAR Framework
Communication breakdowns are among the most common contributing factors in serious preventable adverse events. The SBAR (Situation, Background, Assessment, Recommendation) tool is a standardized, situational communication model originally developed by the U.S. Navy for nuclear submarine communication and adapted for health care by Kaiser Permanente to facilitate concise, critical communication between nurses and prescribers.
Applying SBAR to Acute Heart Failure Deterioration
When escalating clinical concerns regarding an acute heart failure patient, unstructured statements (e.g., "Mr. Davis in Bed 4 doesn't look good and his breathing is worse" ) generate confusion and delayed care. The SBAR framework forces structured diagnostic thinking: ┌─────────────────────────────────────────────────────────────────────────────┐
- │ SBAR Clinical Escalation Framework │
- ├─────────────────┬───────────────────────────────────────────────────────────┤
- │ S = Situation │ • State your name, nursing unit, patient name, and bed │
- │ │ • State the immediate, urgent clinical concern │
- │ │ • Example: "This is Nurse Martinez on 4-West calling about│
- │ │ Mr. Davis in 412. He is experiencing acute respiratory │
- │ │ distress, hypoxia, and oliguria over the last 2 hours." │
- ├─────────────────┼───────────────────────────────────────────────────────────┤
- │ B = Background │ • State primary admission diagnosis, baseline LVEF, and │
- │ │ relevant cardiovascular medical history │
- │ │ • State baseline weight, current intake/output balance, │
- │ │ and active medications (especially inotropes/diuretics) │
- │ │ • Example: "He has ischemic cardiomyopathy, LVEF 20%, │
- │ │ admitted 2 days ago for ADHF. He is receiving continuous│
- │ │ bumetanide at 1 mg/hr and carvedilol 12.5 mg BID. His │
- │ │ baseline dry weight is 82 kg, and today's weight is 87kg"│
- ├─────────────────┼───────────────────────────────────────────────────────────┤
- │ A = Assessment │ • Current vital signs, oxygenation, and physical exam │
- │ │ • Objective hemodynamic, telemetry, and laboratory data │
- │ │ • Example: "His BP dropped from 118/74 to 86/52 mmHg, HR │
- │ │ 112 sinus tachycardia, RR 28, SpO2 88% on room air. He │
- │ │ has bibasilar crackles, cold, clammy extremities, and │
- │ │ urine output is only 10 mL/hr for the last 3 hours. I │
- │ │ assess he is developing cardiogenic shock." │
- ├─────────────────┼───────────────────────────────────────────────────────────┤
- │ R = Recommenda- │ • State explicit, actionable diagnostic and therapeutic │
- │ tion │ proposals; request immediate bedside physician evaluation│
- │ │ • Example: "I recommend you evaluate him at the bedside │
- │ │ immediately. I suggest placing him on 4 L nasal cannula,│
- │ │ holding his evening carvedilol, drawing a STAT metabolic│
- │ │ panel and arterial blood gas, and preparing a low-dose │
- │ │ milrinone or dobutamine infusion for forward perfusion."│
- └─────────────────┴───────────────────────────────────────────────────────────┘
- Patient-Provider Communication: Motivational Interviewing
Adherence to complex heart failure regimens requires substantial lifestyle reorganization: maintaining a strict 2,000 mg/day dietary sodium intake, tracking daily weights, fluid restricting, and taking multiple medications twice daily. Traditional, authoritarian nursing communication—relying on lecturing, warning, or arguing—triggers defensive reactions known as the "righting reflex" and deepens patient resistance.
The Philosophy of Motivational Interviewing (MI)
Motivational Interviewing is a collaborative, person-centered counseling method designed to resolve ambivalence and elicit intrinsic motivation for health behavior change. Rather than telling patients why they must change, the nurse creates a non-judgmental environment that empowers patients to voice their own reasons for change ( "change talk" ).
The OARS Core Communication Skills
O — Open-Ended Questions: Questions that cannot be answered with a simple "yes" or "no," encouraging patients to reflect and speak.
Ineffective Closed Question: "Are you taking your water pills every morning?"
Effective Open Question: "What challenges have you encountered with taking your water pills around your daily morning routine?"
A — Affirmations: Acknowledging the patient's personal strengths, past successes, and sincere efforts, fostering self-efficacy and resilience.
Example: "You have done an impressive job tracking your daily weights on your calendar every single morning this week, even when you were feeling exhausted."
R — Reflective Listening: Repeating, rephrasing, or reflecting the underlying emotion and meaning of what the patient expressed, demonstrating profound empathy and encouraging deeper exploration.
Patient: "I hate this low-salt diet. Everything tastes like paper, and I miss going out to barbecue with my coworkers."
Nurse Reflection: "It sounds like you feel isolated and frustrated because eating low-salt food makes you feel cut off from enjoyable social traditions with your friends."
S — Summarizing: Periodically pulling together the key points of the conversation, highlighting the patient's own statements of desire, ability, reason, and need to change (DARN), and concluding with a clear path forward.
Example: "To make sure I understand everything we discussed: On one hand, you enjoy cooking traditional dishes for your family, but on the other hand, you noticed that eating high-sodium canned broths caused your ankles to swell and put you in the hospital last month. You'd like to explore using fresh garlic, citrus, and herbal seasonings so you can protect your heart while still keeping meals flavorful. Did I capture that accurately?"
Rolling with Resistance and Eliciting Change Talk
When a patient resists (e.g., "I am not going to stop drinking three cups of coffee and sweet tea every day" ), the nurse avoids arguing. By rolling with resistance , the nurse validates the patient's autonomy: "You are the only one who decides what you drink each day. What do you think would happen with your swelling if we replaced just one of those teas with water or decaf?" This invites the patient to evaluate consequences without feeling coerced.
Collaborative Frameworks for Action Planning
The outline asks the CHFN to "use a collaborative framework in action planning." In practice this means the team and the patient build one shared plan with clear owners rather than separate discipline-specific instructions.
Team-Level Action Planning
Shared care plan: One problem list and goal set in the record that every discipline updates (for example, "reach euvolemia and start an SGLT2 inhibitor before discharge").
Clear roles and owners: Each action has a named owner and due date (pharmacist: copay assistance by Friday; dietitian: sodium teaching session; nurse: 7-day appointment).
Huddles and interdisciplinary rounds: Brief daily or weekly check-ins review barriers, labs, and discharge readiness.
Closed-loop communication: Orders and handoffs are read back and confirmed, using SBAR or I-PASS.
Patient-Level Action Planning
Elicit what matters and let the patient choose the priority behavior.
Set a SMART goal: specific, measurable, achievable, relevant, and time-bound (for example, "walk 10 minutes after lunch on 5 days this week").
Brief action planning: Ask permission, help the patient describe what, when, where, and how often, then ask for confidence on a 0-to-10 scale. If confidence is below 7, problem-solve or shrink the goal.
Plan the follow-up: Agree on when and how the team will check progress, and revise the plan together.
Nurse-Led Heart Failure Disease Management & Titration Clinics
One of the most impactful innovations in modern cardiology is the implementation of nurse-led heart failure titration clinics . Despite compelling trial evidence supporting 4-pillar GDMT in HFrEF, real-world registry data (CHAMP-HF, U.S. outpatients) showed that only about 1% of eligible patients received target doses of an ACEi/ARB/ARNI, a beta-blocker, and an MRA at the same time. ┌─────────────────────────────────────────────────────────────────────────────┐
- │ Operational Protocol of a Nurse-Led Titration Clinic │
- ├─────────────────────────────────────────────────────────────────────────────┤
- │ 1. Initial Referral: Patient with HFrEF (LVEF ≤40%) discharged from hospital│
- │ or referred from clinic; initial visit scheduled within 7 to 10 days. │
- │ │
- │ 2. Nursing Assessment: Review vital signs (BP, HR), volume status (JVD, │
- │ edema, lung sounds), lab panel (eGFR, Cr, K+, Na+), and current dosing. │
- │ │
- │ 3. Protocolized Up-Titration: Nurse evaluates standardized algorithm every │
- │ 1 to 2 weeks: │
- │ • Beta-Blocker: Double dose every 2 weeks if euvolemic & HR ≥60 bpm. │
- │ • ARNI (Sacubitril/Valsartan): Double dose every 2-4 weeks if SBP ≥100. │
- │ • MRA (Spironolactone): Titrate to 25-50 mg daily if K+ <5.0 & eGFR >30. │
- │ • SGLT2i (Dapagliflozin/Empagliflozin): Fixed 10 mg daily (no titration).│
- │ │
- │ 4. Safety Intercepts: Routine basic metabolic panel drawn 7-14 days after │
- │ any RAASi, ARNI, or MRA titration. Mandatory physician consult if K+ >5.5│
- │ or creatinine rises >30-50% over baseline. │
- │ │
- │ 5. Demonstrated Clinical Impact: │
- │ • More patients reach target GDMT doses. │
- │ • Cochrane review: fewer hospital admissions and deaths. │
- │ • Earlier detection of adverse lab and blood pressure trends. │
- └─────────────────────────────────────────────────────────────────────────────┘
Nurses working in these specialized clinics operate under signed standardized collaborative practice agreements. Their clinical vigilance ensures that medications are up-titrated systematically rather than left indefinitely at low discharge starting doses.
Clinical Case Scenario: SBAR Escalation and Interdisciplinary Coordination
A 71-year-old male with non-ischemic cardiomyopathy (LVEF 25%, baseline creatinine 1.4 mg/dL) was admitted 36 hours ago with acute decompensated heart failure. He is receiving continuous IV furosemide at 10 mg/hr. The day nurse performs morning rounds and notes significant clinical shifts.
Objective Assessment Findings: Blood pressure has dropped from 122/78 to 92/58 mmHg; heart rate has increased to 108 bpm; oxygen saturation is 93% on 2 L nasal cannula. Auscultation reveals coarse crackles at bilateral lung bases and persistent 2+ pretibial edema. His morning labs demonstrate a serum creatinine rise from 1.4 to 2.4 mg/dL, blood urea nitrogen (BUN) jump from 28 to 62 mg/dL, and serum potassium increase from 4.2 to 5.4 mEq/L. Urine output over the past 6 hours has totaled only 45 mL.
SBAR Escalation: The CHFN immediately contacts the cardiology fellow:
Situation: "This is Nurse Chen caring for Mr. Adams in Room 304. He is developing worsening cardiorenal failure, oliguria, and hypotension under active IV diuresis."
Background: "He is a 71-year-old male with LVEF 25% admitted for acute decompensation, on continuous IV furosemide and home lisinopril 10 mg daily."
Assessment: "His creatinine has spiked to 2.4 mg/dL from 1.4 baseline, potassium is 5.4 mEq/L, BP is 92/58, HR 108, and he has produced only 45 mL urine in 6 hours despite crackles and edema. He is demonstrating severe Cardiorenal Syndrome Type 1 with impaired forward perfusion."
Recommendation: "I recommend pausing the continuous furosemide infusion and holding his lisinopril, obtaining an urgent bedside echocardiogram to evaluate filling pressures and RV function, and initiating a low-dose dobutamine infusion to restore renal perfusion pressure."
Interdisciplinary Resolution: The fellow arrives at the bedside within 10 minutes. The recommendation is accepted: diuresis is held, dobutamine is started at 2.5 mcg/kg/min, and the clinical pharmacist reviews nephrotoxic medications. Within 8 hours, blood pressure improves to 108/66 mmHg, urine output surges to 75 mL/hr, and over the next 48 hours, creatinine recovers to 1.5 mg/dL. The interdisciplinary coordination averted emergency hemodialysis and ICU transfer.
CHFN Exam Traps & Clinical Pearls
Warning
Exam Trap: Do not confuse palliative care with hospice care! Palliative care is an interdisciplinary specialty that should be introduced early in the trajectory of heart failure , provided concurrently alongside aggressive, life-prolonging GDMT, CRT-D, and LVAD therapy. It focuses on relieving symptom distress (dyspnea, fatigue, insomnia) and aligning treatments with patient values. Hospice care, in contrast, is restricted to patients with a certified prognosis of six months or less who have chosen to forgo disease-modifying therapies.
Tip
Exam Trap: In Motivational Interviewing questions, beware of answer options where the nurse provides unsolicited advice, lectures the patient on disease consequences, or argues against patient excuses. The correct MI response always utilizes reflective listening, open-ended questions, or affirmations to elicit the patient's own perspective and intrinsic desire for change.
Important
Clinical Pearl: In an SBAR communication, never end your report at Assessment! An exam question will often test whether the nurse offers a concrete, actionable Recommendation . Suggesting a specific diagnostic test (repeat labs, ECG, echo) or therapeutic adjustment (holding a medication, starting an inotrope, ordering diuresis) demonstrates advanced nursing leadership.